Mimi Yen
Chief Executive Officer PhagePro
Seminars
Wednesday 25th March 2026
Defining the Pathway for Phage Therapeutics in Global Health: Translating Outbreak Prevention from Concept to Clinic
12:00 pm
- Building a clinical development framework for orally administered phage therapeutics targeting cholera prevention in low and middle income countries
- Designing human challenge models to establish clinical proof of concept and regulatory confidence for outbreak ready phage formulations
- Bridging regulatory, manufacturing and market access considerations to enable scalable and sustainable deployment of phage therapies as public health tools
